Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
8
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Calcium Channel Blockade in Primary Aldosteronism
Non Invasive Imaging Methods for Detecting PA：a Clinical PET Study of 18F-Pentixather
Spatial Proteomics Profiles of Aldosterone-producing Adenoma and Unilateral Hyperplasia
The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism
Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study
Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
Outcome of Patients With Primary Aldosteronism
Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary Aldosteronism